The efficacy of cetirizine ophthalmic solution 0.24% (Zerviate) was shown in 3 clinical trials.
Patients had less ocular itching within 15 minutes and the effect persisted for 8 hours after treatment.
In PR-focused wording, the company quotes cetirizine "world-wide exposure representing more than 300 million patient-years".
The recommended dose of Zerviate is one drop in each affected eye twice daily, 8 hours apart.
The most commonly reported adverse reactions were ocular hyperemia (redness), instillation site pain, and reduction in visual acuity, which occurred in roughly 1% to 7% of patients.
Treatment options for allergic conjunctivitis (eye drops) (click here for larger image).
References:
FDA Clears Cetirizine Eye Drops for Allergic Conjunctivitis http://buff.ly/2swY4Sp
No comments:
Post a Comment